Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells. [electronic resource]
Producer: 20100324Description: 3285-95 p. digitalISSN:- 1538-8514
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Blotting, Western
- Brain Neoplasms -- drug therapy
- Caspases -- metabolism
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Synergism
- Fluorodeoxyglucose F18
- Glioblastoma -- drug therapy
- Humans
- Luminescent Measurements
- Mice
- Mice, Nude
- Paclitaxel -- administration & dosage
- Positron-Emission Tomography -- methods
- TNF-Related Apoptosis-Inducing Ligand -- administration & dosage
- Treatment Outcome
- Tumor Burden -- drug effects
- Tumor Suppressor Protein p53 -- genetics
- X-Ray Microtomography -- methods
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.